
Rite Aid Corporation – NYSE:RAD
Rite Aid stock price today
Rite Aid stock price monthly change
Rite Aid stock price quarterly change
Rite Aid stock price yearly change
Rite Aid key metrics
Market Cap | 36.75M |
Enterprise value | 6.23B |
P/E | -0.15 |
EV/Sales | 0.25 |
EV/EBITDA | -15.42 |
Price/Sales | N/A |
Price/Book | -0.34 |
PEG ratio | N/A |
EPS | -14.1 |
Revenue | 24.50B |
EBITDA | 274.28M |
Income | -766.73M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -3.73% |
Oper. margin | -0.22% |
Gross margin | 19.93% |
EBIT margin | -0.22% |
EBITDA margin | 1.12% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRite Aid stock price history
Rite Aid stock forecast
Rite Aid financial statements
Aug 2021 | 6.11B | -100.30M | -1.64% |
---|---|---|---|
Nov 2021 | 6.22B | -36.05M | -0.58% |
Feb 2022 | 6.06B | -389.06M | -6.41% |
Mar 2023 | 6.09B | -241.31M | -3.96% |
May 2022 | 8549773000 | 8.55B | 100.1% |
---|---|---|---|
Aug 2022 | 8367125000 | 8.70B | 104.02% |
Nov 2022 | 8209774000 | 8.61B | 104.92% |
Mar 2023 | 7527362000 | 8.16B | 108.53% |
Aug 2021 | 25.72M | -35.84M | 38.20M |
---|---|---|---|
Nov 2021 | -3.03M | -20.70M | 32.46M |
Feb 2022 | 342.71M | -22.83M | -435.45M |
Mar 2023 | 266.41M | -14.18M | -198.13M |
Rite Aid alternative data
Aug 2023 | 47,000 |
---|---|
Sep 2023 | 47,000 |
Oct 2023 | 47,000 |
Nov 2023 | 47,000 |
Dec 2023 | 47,000 |
Jan 2024 | 47,000 |
Feb 2024 | 47,000 |
Mar 2024 | 47,000 |
Apr 2024 | 47,000 |
May 2024 | 47,000 |
Jun 2024 | 47,000 |
Jul 2024 | 47,000 |
Rite Aid other data
Period | Buy | Sel |
---|---|---|
Jul 2021 | 0 | 28384 |
Dec 2021 | 14350 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Purchase | DONIGAN HEYWARD R officer: President and CEO | Common Stock | 14,350 | $13.94 | $199,967 | ||
Sale | KONRAD JOCELYN Z | Common Stock | 28,384 | $15.42 | $437,568 | ||
Option | STANDLEY JOHN T | Non-Qualified Stock Option (right to buy) | 168,800 | N/A | N/A | ||
Option | STANDLEY JOHN T | Common Stock | 168,800 | N/A | N/A | ||
Sale | POTTER MYRTLE S | Common Stock | 28,189 | N/A | N/A | ||
Option | DONLEY DOUGLAS E | Non-Qualified Stock Option (right to buy) | 34,106 | N/A | N/A | ||
Sale | DONLEY DOUGLAS E | Common Stock | 34,106 | N/A | N/A | ||
Option | DONLEY DOUGLAS E | Common Stock | 34,106 | N/A | N/A | ||
Option | MONTINI TONY | Non-Qualified Stock Option (right to buy) | 150,200 | N/A | N/A | ||
Sale | MONTINI TONY | Common Stock | 353,194 | N/A | N/A |
Quarter | Transcript |
---|---|
Q4 2023 20 Apr 2023 | Q4 2023 Earnings Call Transcript |
Q3 2023 21 Dec 2022 | Q3 2023 Earnings Call Transcript |
Q2 2023 29 Sep 2022 | Q2 2023 Earnings Call Transcript |
Q1 2023 23 Jun 2022 | Q1 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Ms. Heyward Rutledge Donigan B.A. (1961) Pres Chief Executive Officer & Director | $2,180,000 |
Ms. Jocelyn Zazyczny Konrad (1970) Executive Vice President & Chief Pharmacy Officer | $1,360,000 |
Mr. James Joseph Peters Jr. (1972) Chief Operating Officer | $1,310,000 |
Mr. Matthew C. Schroeder (1970) Chief Financial Officer & Executive Vice President | $1,170,000 |
Mr. Justin L. Mennen (1981) Executive Vice President & Chief Information Officer | $731,150 |
CVS: A High Cash Flow Yield, But A Low Return On Capital
CVS Health Earnings And 2023 Outlook: Bearish On Oak Street Buyout
C-Suite Transitions: Rite Aid CEO Departs Abruptly
Unilever Or Procter & Gamble: Which Consumer Goods Giant Is Right For Your Portfolio?
Rite Aid: Time For A Recovery Buy
What's Your Risk Appetite For Kroger?
Walgreens: Cheap, But Has Some Issues
Rite Aid 'Defaulted' According To S&P - Are They Eventually Headed Into Ch.11?
Rite Aid Corporation 2023 Q1 - Results - Earnings Call Presentation
-
What's the price of Rite Aid stock today?
One share of Rite Aid stock can currently be purchased for approximately $0.61.
-
When is Rite Aid's next earnings date?
Unfortunately, Rite Aid's (RAD) next earnings date is currently unknown.
-
Does Rite Aid pay dividends?
No, Rite Aid does not pay dividends.
-
How much money does Rite Aid make?
Rite Aid has a market capitalization of 36.75M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1.94% to 24.09B US dollars.
-
What is Rite Aid's stock symbol?
Rite Aid Corporation is traded on the NYSE under the ticker symbol "RAD".
-
What is Rite Aid's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Rite Aid?
Shares of Rite Aid can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Rite Aid's key executives?
Rite Aid's management team includes the following people:
- Ms. Heyward Rutledge Donigan B.A. Pres Chief Executive Officer & Director(age: 64, pay: $2,180,000)
- Ms. Jocelyn Zazyczny Konrad Executive Vice President & Chief Pharmacy Officer(age: 55, pay: $1,360,000)
- Mr. James Joseph Peters Jr. Chief Operating Officer(age: 53, pay: $1,310,000)
- Mr. Matthew C. Schroeder Chief Financial Officer & Executive Vice President(age: 55, pay: $1,170,000)
- Mr. Justin L. Mennen Executive Vice President & Chief Information Officer(age: 44, pay: $731,150)
-
How many employees does Rite Aid have?
As Jul 2024, Rite Aid employs 47,000 workers.
-
When Rite Aid went public?
Rite Aid Corporation is publicly traded company for more then 45 years since IPO on 17 Mar 1980.
-
What is Rite Aid's official website?
The official website for Rite Aid is riteaid.com.
-
Where are Rite Aid's headquarters?
Rite Aid is headquartered at 1200 Intrepid Avenue, Philadelphia, PA.
-
How can i contact Rite Aid?
Rite Aid's mailing address is 1200 Intrepid Avenue, Philadelphia, PA and company can be reached via phone at +1 717 761 2633.
Rite Aid company profile:

Rite Aid Corporation
riteaid.comNYSE
47,000
Medical - Pharmaceuticals
Healthcare
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. As of February 26, 2022, the company operated 2,450 retail pharmacy locations in 17 states. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
Philadelphia, PA
CIK: 0000084129
ISIN: US7677548726
CUSIP: 767754872